Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions
Clinical trial NCT00837915 · COMPLETED
Trial details
- NCT number
- NCT00837915
- Sponsor
- Ranbaxy Laboratories Limited
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2002-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.